Mild cognitive impairment (MCI) has received increasing attention not only because of its potential as a precursor for Alzheimer's disease (AD), but also as a predictor of conversion to other neurodegenerative diseases. Although MCI has been defined clinically, accurate and efficient diagnosis is still challenging. While neuroimaging techniques hold promise, compared to commonly-used biomarkers including amyloid plaques, tau protein levels and brain tissue atrophy, neuroimaging biomarkers are less well validated. In the present paper, we propose a connectomes-scale assessment of structural and functional connectivity in MCI via two independent multimodal DTI/fMRI datasets. We first used DTI-derived structural profiles to explore and tailor ...
Over the past years, several studies on Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD)...
The human connectome refers to a comprehensive description of the brain's structural and functional ...
Background: Early prediction of disease progression in patients with amnestic mild cognitive impairm...
Mild cognitive impairment (MCI) has received increasing attention not only because of its potential ...
Mild cognitive impairment (MCI) has received increasing attention not only because of its potential ...
Due to the difficulties in establishing correspondences between functional regions across individual...
Background: Early prediction of disease progression in patients with amnestic mild cognitive impairm...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a severe derangement of co...
Alzheimerâs disease (AD) is the most common form of dementia among older people and increasing longe...
Mild cognitive impairment is defined as greater cognitive decline than expected for a person at a pa...
The arc of progression in the most common neurological aiction known as Alzheimer's Disease (AD), is...
Different imaging modalities provide essential complementary information that can be used to enhance...
International audienceAlzheimer's disease (AD) is increasingly considered as a disconnection syndrom...
Background: Alzheimer's disease disrupts the topological architecture of whole-brain connectivity (i...
Mild cognitive impairment (MCI), often a prodromal phase of Alzheimer’s disease (AD), is frequently ...
Over the past years, several studies on Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD)...
The human connectome refers to a comprehensive description of the brain's structural and functional ...
Background: Early prediction of disease progression in patients with amnestic mild cognitive impairm...
Mild cognitive impairment (MCI) has received increasing attention not only because of its potential ...
Mild cognitive impairment (MCI) has received increasing attention not only because of its potential ...
Due to the difficulties in establishing correspondences between functional regions across individual...
Background: Early prediction of disease progression in patients with amnestic mild cognitive impairm...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a severe derangement of co...
Alzheimerâs disease (AD) is the most common form of dementia among older people and increasing longe...
Mild cognitive impairment is defined as greater cognitive decline than expected for a person at a pa...
The arc of progression in the most common neurological aiction known as Alzheimer's Disease (AD), is...
Different imaging modalities provide essential complementary information that can be used to enhance...
International audienceAlzheimer's disease (AD) is increasingly considered as a disconnection syndrom...
Background: Alzheimer's disease disrupts the topological architecture of whole-brain connectivity (i...
Mild cognitive impairment (MCI), often a prodromal phase of Alzheimer’s disease (AD), is frequently ...
Over the past years, several studies on Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD)...
The human connectome refers to a comprehensive description of the brain's structural and functional ...
Background: Early prediction of disease progression in patients with amnestic mild cognitive impairm...